Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas  Lan Peng, M.D., Yong Wen, M.D., Yulong.

Slides:



Advertisements
Similar presentations
Deletions of the INK4A Gene Occur in Malignant Peripheral Nerve Sheath Tumors but not in Neurofibromas  Helen P. Kourea, Irene Orlow, Bernd W. Scheithauer,
Advertisements

Tsai-Der Chuang, Ph.D., Omid Khorram, M.D., Ph.D. 
Sphingosine pathway deregulation in endometriotic tissues
Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata  Hongbo Wang, MD, Mamatha Mahadevappa, PhD, Karen Yamamoto,
The CB2 cannabinoid receptor regulates human sperm cell motility
Cellular senescence in usual type uterine leiomyoma
Volume 28, Issue 3, Pages (November 2007)
Fertility and Sterility
Increased expression of platelet-derived growth factor C messenger ribonucleic acid in uterine leiomyomata  Yuh-Ming Hwu, M.D., Sheng-Hsiang Li, Ph.D.,
Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient  Irina K. Dimitrova, M.D., Jennifer K. Richer,
Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway  Tatsuo Nakahara, M.D., Akira Iwase, M.D., Ph.D.,
Gene expression profiling of human peri-implantation endometria between natural and stimulated cycles  Yunao Liu, M.Sc., Kai-Fai Lee, Ph.D., Ernest H.Y.
Eutopic endometrial interleukin-18 system mRNA and protein expression at the level of endometrial-myometrial interface in adenomyosis patients  Hong-Yuan.
Agnieszka Malcher, M. S. , Natalia Rozwadowska, Ph. D
Chakradhari Sharan, Ph. D. , Sunil K. Halder, Ph. D
Progestin-induced heart and neural crest derivatives expressed transcript 2 is associated with fibulin-1 expression in human endometrial stromal cells 
Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata 
Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes  Magnus Centlow, M.Sc., Piero Carninci,
Marta Gianzo, J. D. , Iraia Muñoa-Hoyos, J. D
Expression of cell cycle regulatory genes during primordial-primary follicle transition in the mouse ovary  Chang-Eun Park, M.S., Kwang-Yul Cha, M.D.,
Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues 
Effects of letrozole and clomiphene citrate on the expression of HOXA10 and integrin αvβ3 in uterine epithelium of rats  Shi Hua Bao, M.D., Ph.D., Shi.
Regulation of myeloid ecotropic viral integration site 1 and its expression in normal and abnormal endometrium  Linli Hu, M.D., Haixia Li, M.D., CindyTzu-Ling.
Panagiotis Bakas, M. D. , Angelos Liapis, M. D
Investigation of the human stem cell factor KIT ligand gene, KITLG, in women with 46,XX spontaneous premature ovarian failure  Emily S. Hui, B.A., Ekemini.
Endometrial expression and in vitro modulation of the iron transporter divalent metal transporter-1: implications for endometriosis  Carlos Patricio Alvarado-Díaz,
Ying-Ying Yu, Ph. D. , Cui-Xiang Sun, Ph. D. , Yin-Kun Liu, Ph. D
Tumor necrosis factor α up-regulates endometrial milk fat globule–epidermal growth factor 8 protein production via nuclear factor κB activation, resulting.
Interleukin-18 system messenger RNA and protein expression in human endometrium during the menstrual cycle  Hong-Yuan Huang, M.D., She-Hung Chan, B.Sc.,
Dynamic alterations in the expression and localization of ACTL7a during capacitation in mouse spermatozoa  Jun Fu, Ph.D., Wei Song, Ph.D., Shudong Zong,
Sana M. Salih, M. D. , Salama A. Salama, Ph. D. , Amin A. Fadl, Ph. D
Studies of gene expression in human cumulus cells indicate pentraxin 3 as a possible marker for oocyte quality  Xingqi Zhang, Ph.D., Nadereh Jafari, Ph.D.,
Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity  Beth W. Rackow, M.D., Hugh S. Taylor, M.D.  Fertility.
Volume 18, Issue 2, Pages (April 2005)
Shi-Ling Chen, M. D. , M. Sc. , Xiao-Yun Shi, M. D. , M. Sc
Yan Wen, M. D. , Rudy Quintero, M. D. , Bertha Chen, M. D
Molecular Monitoring of Chronic Myelogenous Leukemia
Endometrial LGR7 expression during menstrual cycle
Mu opioid receptor in the human endometrium: dynamics of its expression and localization during the menstrual cycle  Lide Totorikaguena, B.S., Estibaliz.
Activating transcription factor 3 gene expression suggests that tissue stress plays a role in leiomyoma development  Mark Payson, M.D., Minnie Malik,
Nonsense mutation of EMX2 is potential causative for uterus didelphysis: first molecular explanation for isolated incomplete müllerian fusion  Shan Liu,
Eszter Ducza, Ph. D. , Róbert Gáspár, Ph. D. , Attila Mihályi, Ph. D
HOXA10 mutations in congenital absence of uterus and vagina
A modest but significant effect of CGB5 gene promoter polymorphisms in modulating the risk of recurrent miscarriage  Kristiina Rull, M.D., Ph.D., Ole.
Increased progesterone receptor expression in uterine leiomyoma: correlation with age, number of leiomyomas, and clinical symptoms  Anastasia Tsigkou,
Aromatase expression in abdominal omental/visceral and subcutaneous fat depots: a comparison of pregnant and obese women  Suman Rice, Ph.D., Bijal Patel,
Jieqiang Lv, M. D. , Xueqiong Zhu, M. D. , Ph. D
Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-
Spatial differences in biologic activity of large uterine leiomyomata
Granulosa–lutein cell growth differentiation factor-9 (GDF-9) messenger RNA and protein expression in in vitro fertilization (IVF) cycles: relation to.
Erica E. Marsh, M. D. , Zhihong Lin, Ph. D. , Ping Yin, Ph. D
Kei Wada, Chihaya Maesawa, Toshihide Akasaka, Tomoyuki Masuda 
Cryptotanshinone reverses ovarian insulin resistance in mice through activation of insulin signaling and the regulation of glucose transporters and hormone.
Human myometrium and leiomyomas express gonadotropin-releasing hormone 2 and gonadotropin-releasing hormone 2 receptor  Jason D. Parker, D.O., Minnie.
Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata  Jian-Jun Wei, M.D., Luis.
Lin Mu, Ph. D. , Wei Zheng, Ph. D. , M. D. , Liang Wang, Ph. D
Identification of differential gene expression in germinal vesicle vs
Expression of leucine-rich repeat-containing G-protein-coupled receptors in the human cyclic endometrium  Claudia A. Krusche, Ph.D., Tina Kroll, Henning.
Daniela Zuccarello, Ph. D. , Andrea Garolla, Ph. D
Cellular senescence in usual type uterine leiomyoma
Nerea Subirán, J. D. , Ekaitz Agirregoitia, J. D. , Asier Valdivia, Ph
Jason Yen-Ping Ho, M. D. , Weng Chi Man, Ph. D. , Yan Wen, M. D
Se-Jin Yoon, Ph. D. , Deog-Bon Koo, Ph. D. , Jung Sun Park, M. Sc
An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells  Masao Izawa, Ph.D., Tasuku Harada, M.D., Fuminori.
Exon Skipping in IVD RNA Processing in Isovaleric Acidemia Caused by Point Mutations in the Coding Region of the IVD Gene  Jerry Vockley, Peter K. Rogan,
Sequence variation analysis of the prolactin receptor C-terminal region in women with premature ovarian failure  Anne Bachelot, M.D., Ph.D., Justine Bouilly,
Nicotine induces apoptosis in TM3 mouse Leydig cells
Bradford Coffee, Fuping Zhang, Stephanie Ceman, Stephen T
Kálmán A. Kovács, M. D. , Ph. D. , Ferenc Lengyel, Ph. D
K. Miura, M. Obama, K. Yun, H. Masuzaki, Y. Ikeda, S. Yoshimura, T
Presentation transcript:

Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas  Lan Peng, M.D., Yong Wen, M.D., Yulong Han, M.D., Anran Wei, Guizhi Shi, M.D., Masashi Mizuguchi, M.D., Peng Lee, M.D., Eva Hernando, Ph.D., Khush Mittal, M.D., Jian-Jun Wei, M.D.  Fertility and Sterility  Volume 91, Issue 6, Pages 2664-2675 (June 2009) DOI: 10.1016/j.fertnstert.2007.10.083 Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Differential expression of IGF-1 mRNA and protein in fibroids. (A) Semiquantitative RT-PCR analysis of IGF-1 cDNA in fibroids (even numbers) and matched myometrium (odd numbers). G3PDH was used as an internal control. (B) Arrow lines illustrating the normalized values of IGF-1/G3PDH cDNA (y axis, %) in fibroids and matched myometrium. No statistical significance of mean values between fibroids and myometrium was noted. (C) Dot plot of the relative amounts of IGF-1 cDNA in the secretory (SE) and proliferative (PE) phases. Each dot represents an individual case. (D) Significant differences of mean values of IGF-1 expression between SE and PE in both myometrium and fibroids. (E) Photomicrographs of immunoreactivities for IGF-1 in fibroids and matched myometrium. (F) Significant analysis of the net gains of IGF-1 immunoreactivity associated with tumor sizes. ∗P<.05; ∗∗P<.01. The tumor sizes and numbers of cases are listed below the histogram bars. y axis in B, C, and D indicates percentage of IGF-1/G3PDH ratio. Fertility and Sterility 2009 91, 2664-2675DOI: (10.1016/j.fertnstert.2007.10.083) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Differential expression of IGF-2 and different usages of IGF-2 promoters in fibroids. (A) Photonegative images of the multiplex RT-PCR products representing the cDNA from specific IGF-2 isoforms in large (L-ULM) and small (S-ULM) fibroids, and matched myometrium (control) in eight cases. Primers used for the RT-PCR are listed on the right (see B). G3PDH was used as a RNA loading control. (B) A sketch diagram illustrating genomic organization of IGF-2, including genomic DNA (double line) and relative locations of each of 10 coding (black box) and non-coding (open box) exons. Promoters P1 to P4 in exons 1, 4, 6, and 7 are shown on top. The forward (F) and reverse (R) primers for the amplification of specific isoforms from different promoter usage are shown below. (C) The relative abundances of IGF-2 cDNA products (IGF-2/G3PDH) and the significance values from each isoform were analyzed and are listed in the histogram. (D) Photomicrographs illustrating an example of immunoreactivity for IGF-2 in fibroids and matched myometrium (∗P<.05). (E) Mean values of net gain of IGF-2 gene products in different tumor sizes. There was a positive correlation between IGF-2 immunoreactivity and tumor size, but no statistical significance was obtained (P>.05). The tumor sizes and numbers of cases are listed below. Fertility and Sterility 2009 91, 2664-2675DOI: (10.1016/j.fertnstert.2007.10.083) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Methylation analysis of IGF-2 promoter 1 and 2 in fibroids and myometrium. (A) Two cases with significant over-expression of IGF-2 in both large (L) and small (S) fibroids (using IGF-2 P1 and P2) were selected for methylation analysis. (B) Sketch diagram of the genomic DNA immediately upstream of IGF-2 P1 (518 base pairs) and P2 (485 base pairs) selected for methylation analysis. The sites of restriction enzyme SmaI and HaeIII were indicated by arrows. Arrow of SmaI∗ is a polymorphic site. (C) Methylation analysis of IGF-2 P1 and P2 in fibroids and matched myometrium (MM). Insulin-like growth factor-2 promoter DNAs with and without bismuth treatment were amplified by PCR, then digested with SmaI (P1) and HaeIII (P2), and size-fractionated in agarose gels. The methylation patterns of P1 and P2 in fibroids were identical to that in myometrium, in which only one allele had high levels of methylation. Fertility and Sterility 2009 91, 2664-2675DOI: (10.1016/j.fertnstert.2007.10.083) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Figure 4 Differential expressions of p-AKT and p-S6K in large cohort fibroids and matched myometrium. (A) Photomicrographs illustrating examples of distinct and moderate immunoreactivities for p-AKT and p-S6K in fibroids, but not in myometrium. (B) The percentage of p-AKT- and p-S6K-positive fibroids in a total of 180 cases. (C, D) Differential expressions of p-AKT (C) and p-S6K (D) in association with tumor size. The net gain values of immunoreactivity from fibroids against myometrium (ULM-MM) are shown on the y axis. The tumor sizes and case numbers are listed below the histogram bars. (E) Example of increased p-AKT, but not total AKT protein, in fibroids (ULM) in comparison to matched myometrium (MM). Actin was used as loading control. Fertility and Sterility 2009 91, 2664-2675DOI: (10.1016/j.fertnstert.2007.10.083) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Figure 5 Differential expressions of TSC gene products hamartin and tuberin in fibroids. (A) Photomicrographs illustrating the patterns of immunoreactivity for hamartin and tuberin in fibroids and myometrium. (B) Differential expression of hamartin and tuberin in association with tumor size. The net gain values of immunoreactivity from fibroids against myometrium (ULM-MM) are shown on the y axis. The tumor sizes and case numbers are listed below the histogram bars. (C) Differential expression of hamartin and tuberin in five small (S) and five large (L) fibroids by Western blot analysis. Four matched myometrium (MM) were used as controls. Erk was used as a protein loading control. (D) Quantitative analysis of hamartin and tuberin protein product in fibroids (ULM) and myometrium (MM) scaled from Western blot bands listed in C and normalized by Erk protein (y axis). There was significant over-expression of hamartin and under-expression of tuberin in fibroids compared with matched myometrium (P<.05). No significance was found between large and small fibroids. Fertility and Sterility 2009 91, 2664-2675DOI: (10.1016/j.fertnstert.2007.10.083) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions